Robin Monotti
66.9K subscribers
15.8K photos
8.73K videos
625 files
30.1K links
Official Robin Monotti Channel
Donations:
robinmonotti.substack.com/
Group is @robinmggroup
We don't DM from this channel account.
Rule: Be polite & respectful.
Download Telegram
VACCINE PASSPORTS
USA ❌
RUSSIA ❌
MEXICO ❌
EU ✅
CHINA ?
UK ✅
ISRAEL ✅
PRESS RELEASE - FOR IMMEDIATE RELEASE
Doctors and Scientists Accuse Medical Regulator of Downplaying COVID-19 Vaccine Dangers
The European Medicines Agency is misleading citizens into medical experimentation, experts warn
April 7th, 2021
As vaccine passports are being proposed around the world, doctors and scientists from 25 countries have contested regulators' claims that COVID-19 vaccines are safe.
On April 1st the experts issued a rebuttal letter to the European Medicines Agency (EMA), following the regulator’s dismissal of their earlier warnings regarding COVID-19 vaccine dangers from clotting and bleeding.
Within days of the EMA receiving the group’s original letter on March 1st, outlining risks of blood disorders from COVID-19 vaccines, over a dozen countries suspended the AstraZeneca vaccine following deaths from clotting and bleeding, as the doctors had warned.
On March 23rd, however, the EMA dismissed the group’s concerns as relating to “minor” and “rare” events, concluding that “a positive benefit-risk balance has been established.”
The doctors and scientists have hit back, accusing the EMA of misleading the public on the vaccines’ true risk-benefit profile. “Your reply of March 23 is unconvincing and unacceptable,” they wrote, noting that recorded cases of life-threatening cerebral venous thrombosis (CSVT) post-vaccination likely “represent just the tip of a huge iceberg”. Common reactions to vaccination, including headache, nausea, blurred vision and vomiting, they state, are symptoms of CSVT, and should be assessed as such, immediately.
Clotting and bleeding after vaccination can also “be expected to increase with each re-vaccination, and each intervening coronavirus exposure” the group warned. Over time “this renders both repeated vaccination and common coronaviruses dangerous to young and healthy age groups, for whom - in the absence of ‘vaccination’ - COVID-19 poses no substantive risk."
“Such is the real risk-benefit analysis of the COVID-19 ‘vaccines’. Either the EMA lacks the subject-matter expertise to appreciate the molecular science of this reality, or it lacks the medical ethics to act accordingly.”
The group, Doctors for Covid Ethics, which includes professors of immunology and microbiology, described the EMA’s responses to their concerns as “unscientific”, “vague”, and lacking credibility. They have offered to liaise with the agency to mitigate against vaccination risks and ethics violations, including helping the EMA to “craft a focussed pharmacovigilance plan.” The experts stress that all signs and symptoms of thrombosis post vaccination, such as headaches and nausea, must be assessed using D-dimer tests, in order to “rapidly diagnose” thrombotic events.
The group warned that continuing to administer inadequately tested, and inadequately monitored, gene-based COVID-19 vaccines represents dangerous medical experimentation, whose “true risks far outweigh any theoretical benefits”, reflecting “serious violations of medical ethics and citizens’ medical rights.”
“Misleading populations into accepting investigational agents such as the gene-based COVID-19 ‘vaccines’, or coercing them through ‘vaccine passports’, constitutes clear and egregious violations of the Nuremberg Code”, they caution.
The letter is addressed to Emer Cooke, Executive Director of the EMA, and was copied to the lawyer Reiner Fuellmich, Charles Michel, President of the Council of Europe, and Ursula von der Leyen, President of the European Commission. 
Forwarded from Mike Yeadon
Since receiving the correspondence, the EMA has maintained its public advice of March 31st that vaccine-related clotting is “very rare”, and that “no evidence” of a causal relationship between COVID-19 vaccines and blood clotting exists.        

Link to Doctors for Covid Ethics rebuttal letter to EMA (April 1st): https://doctors4covidethics.medium.com/rebuttal-letter-to-european-medicines-agency-from-doctors-for-covid-ethics-april-1-2021-7d867f0121e
Link to EMA letter to Doctors for Covid Ethics (March 23rd):  https://doctors4covidethics.medium.com/reply-from-the-european-medicines-agency-to-doctors-for-covid-ethics-march-23-2021-d6760984dd06
Doctors for Covid Ethics is a group of over 100 doctors and scientists from 25 countries.
Web: https://doctors4covidethics.medium.com
Twitter: https://twitter.com/Drs4CovidEthics
For comment contact Professor Sucharit Bhakdi MD: sucharit.bhakdi@gmx.de or Associate Professor Michael Palmer MD: mpalmer@uwaterloo.ca

Further resources
Original Doctors for Covid Ethics letter to EMA (Delivered March 1st):  https://doctors4covidethics.medium.com/urgent-open-letter-from-doctors-and-scientists-to-the-european-medicines-agency-regarding-covid-19-f6e17c311595
List of signatories: https://doctors4covidethics.medium.com/doctors-for-covid-ethics-signatories-15878f9ff76
Video statement (March 11th) by Professor Sucharit Bhakdi, Professor Emeritus of Medical Microbiology and Immunology and Former Chair, Institute of Medical Microbiology and Hygiene: https://lbry.tv/@Doctors4CovidEthics:d/Prof.-Sucharit-Bhakdi-statement-on-EMA-open-letter.ENG:0
Doctors, scientists, lawyers and colleagues in allied disciplines can sign the open letter by sending their name, qualifications, areas of expertise and country of practice to: Doctors4CovidEthics@protonmail.com, with web verification (eg workplace or registration link, not for publication).
END
###
"Comparing weekly mortality in 24 European countries, the findings in this paper suggest that more severe lockdown policies have not been associated with lower mortality. In other words, the lockdowns have not worked as intended. Further tests also show that early interventions offered no additional benefits or effectiveness and even indicate that the lockdowns of the spring of 2020 were associated with significantly more deaths in the particular age group between 60 and 79 years.
These general findings are consistent with the results of previous papers using a variety of simpler methods to test the effects of lockdowns. Contrary to persistent political claims, as indicated by recent research in Bendavid et al. (2021), the traditional approach of carefully disseminating public information about the epidemic and relying on voluntary measures may have represented the only policy significantly associated with fewer cases than no reaction at all, although almost all other countries went substantially further. Likewise, much has been made of the timing of lockdowns, but the present analysis does not indicate that early lockdowns were more effective. Examples also suggest that lockdown timing may not have been a significant determinant of mortality development: while Belgium and Portugal were among the countries that locked down soon after seeing the first COVID-related death, the former saw an 11% increase in mortality, compared with the preceding three years, while the latter only saw a 2% increase. Among countries that locked down later, the UK experienced an 18% higher mortality than the preceding years, while German mortality in the first half of 2020 was almost exactly average for the time of the year. As such, the data illustrate that strategic examples as are often used in popular media can be highly misleading, which necessitates a more comprehensive evaluation of lockdown efficacy.
The main problem at hand is therefore that the evidence presented here suggests that lockdowns have not significantly affected the development of mortality in Europe. They have nevertheless wreaked economic havoc in most societies and may lead to a substantial number of additional deaths for other reasons. A British government report from April for example assessed that a limited lockdown could cause 185,000 excess deaths over the next years, while UNICEF warns of an increase in child marriages, owing to the economic effects of Western lockdowns in developing countries (DHSC 2020; Philipose and Aika 2021). Evaluated as a whole, at a first glance, the lockdown policies of the Spring of 2020 therefore appear to be substantial long-run government failures."

Did Lockdown Work? An Economist’s Cross-Country Comparison | CESifo Economic Studies | Oxford Academic
https://academic.oup.com/cesifo/advance-article/doi/10.1093/cesifo/ifab003/6199605
COVID19 MORTALITY: 0.15%
FLU MORTALITY: 0.1%

"All systematic evaluations of seroprevalence data converge that SARS‐CoV‐2 infection is widely spread globally. Acknowledging residual uncertainties, the available evidence suggests average global IFR of ~0.15% and ~1.5‐2.0 billion infections by February 2021 with substantial differences in IFR and in infection spread across continents, countries, and locations."

Reconciling estimates of global spread and infection fatality rates of COVID‐19: an overview of systematic evaluations - Ioannidis - - European Journal of Clinical Investigation - Wiley Online Library
https://onlinelibrary.wiley.com/doi/10.1111/eci.13554
Forwarded from Mike Yeadon
I see it as definitely coercing people to accept an experimental treatment which, for the majority of the unvaccinated, is inappropriate. In a low but real number of cases, that coercion will result in the deaths of those pressured into it.

This is clearly in breach of our human rights (several sections) per the recent Council of Europe declaration (Jan 27 2021):

https://pace.coe.int/en/files/29004/html

<<7.3 with respect to ensuring high vaccine uptake:
7.3.1 ensure that citizens are informed that the vaccination is NOT mandatory and that no one is politically, socially, or otherwise pressured to get themselves vaccinated, if they do not wish to do so themselves;
7.3.2 ensure that no one is discriminated against for not having been vaccinated, due to possible health risks or not wanting to be vaccinated; >>

Coercing people to accept an unwanted, experimental treatment (all these vaccines are years from completion of their pivotal - Phase 3 - studies) by definition without consent breaches the Nuremberg Code against human experimentation, which derived from the Nazi ‘Doctors Trials’, at the conclusion of which some were put to death.
Forwarded from Mike Yeadon
Interesting blog about covid19 gene based vaccines & thromboembolic event risk. Worth a scan read, just to become more aware of the stink of hypocrisy & complete lack of interest in the health & safety of citizens in notionally liberal democracies:

Anthrax Vaccine -- posts by Meryl Nass, M.D.
This blog began in 2007, focusing on anthrax vaccine, and later expanded to other public health and political issues. The blog links to media reports, medical literature, official documents and other materials.






























Tuesday, April 6, 2021
Latest vaccine flip-flop gives the vaccine game away

The Venous Sinus System, where slow blood flow apparently predisposes to clots after the Astra-Zeneca Covid vaccination

The Astra-Zeneca "cheap and easy to store" "workhorse" vaccine causes blood clots in general, and in particular clots in the venous sinuses of the brain, which have killed or wounded a number of people, especially women under 55.  
From StatNews:

Disorders caused by blood clots, including heart attacks, vein thromboses, and strokes, are common. But the types of clots that may be linked to the AstraZeneca vaccine are exceedingly rare. They have been marked by low levels of platelets — the blood cell fragments that normally cause clotting. 

The types of clots seen include cerebral venous sinus thrombosis, or CVST, a type of blood clot that occurs in the veins that drain blood from the brain, and a similar condition in the abdomen, known as splanchic vein thrombosis. The clots sometimes occur in combination with bleeding.
From the Washington Post:

The European Medicines Agency, the European Union’s regulator, said it is investigating at least 44 cases of the rare brain clots and at least 14 deaths among about 9.2 million vaccinations in 30 European countries...
As of March 29, Germany’s regulator has reported 31 cases of the unusual blood clots in 2.7 million people vaccinated with the AstraZeneca vaccine, nine of whom have died.



The J and J vaccine was also associated with blood clots in the clinical trial data presented to FDA.  Both vaccines use an adenovirus vector to deliver DS DNA that codes for spike protein, and human cellular machinery produces this protein, for an uncertain period of time in uncertain quantities. So blood clotting may be due to the adenovirus vector, or to the spike protein, or to something entirely different.
The mRNA vaccines use mRNA to code for the spike, also using cellular machinery to produce the spike protein.  The end result of all 4 vaccines is similar, and again, we do not know for how long the body makes this protein.
If the spike itself induces clotting, which is a reasonable hypothesis scientists have put forth, but is unproven, then all 4 vaccines would be thrombogenic (induce clotting). Dr. Patrick Whelan tried to warn the FDA about this possibility, but was ignored.  He wrote:

Meinhardt et al. (Nature Neuroscience 2020, in press) show that the spike protein in brain endothelial cells is associated with formation of microthrombi (clots), and like Magro et al. do not find viral RNA in brain endothelium. In other words, viral proteins appear to cause tissue damage without actively replicating virus.

Is it possible the spike protein itself causes the tissue damage associated with Covid-19? Nuovo et al (in press) have shown that in 13/13 brains from patients with fatal COVID-19, pseudovirions (spike, envelope, and membrane proteins) without viral RNA are present in the endothelia of cerebral microvessels.
This is frightening information, providing a strong hint of the spike protein's potential toxicity. 
--------------
From StatNews:


Many countries are counting on AstraZeneca’s vaccine. The European Union alone has purchased 400 million doses of the vaccine. The United States has bought 300 million doses of the vaccine, the largest pre-purchase deal of all those contracted by Operation Warp Speed, the vaccine and therapeutics fast-tracking project started during the Trump administration.

How did 20 countries deal with the clotting issue?
Forwarded from Mike Yeadon
First they halted the vaccinations until they could review all the available data and get their narratives aligned. They then decided the A-Z vaccine did cause clots.  But you cannot waste Covid vaccine (unless you are Emergent BioSolutions) so it had to be used.  But in whom?  In poorer countries of course.  But what about the supplies already purchased by western Europe?
The public health leaders came up with a great idea.  Restrict it, just for the elderly.  If they die, there is almost always a preexisting condition to blame. 
But apparently that wasn't sufficient.  So they started testing this vaccine in children. 
A few countries stopped the A-Z vaccine altogether.
France, Germany, Sweden and Canada are among those restricting its use in younger people, while Denmark and Norway have maintained a complete pause.
What about the US?  Despite the problems with EBS's failed production of the Johnson and Johnson/Janssen vaccine (up to 150 million doses may need to be thrown away) the US seems to be swimming in vaccine at the moment, and any adult can sign up for a dose. It is likely that Astra-Zeneca's 300 million doses will be written off, in addition to the failed J and J doses.
From StatNews:

Whether it will be used here remains an open question. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told Reuters last week that the U.S. may not need the vaccine.

“My general feeling is that given the contractual relationships that we have with a number of companies, that we have enough vaccine to fulfill all of our needs without invoking AstraZeneca,” Fauci said, without referring to the clotting problem now associated with the vaccine.

Can you imagine what the informed consent for the Oxford A-Z clinical trial in children says?  "We are testing a vaccine known to cause lethal blood clots, in children, who almost never get severe Covid--therefore the benefits won't exceed the risks of the vaccine in this demographic.  Your child is at greater risk of dying from the vaccine than the disease."  How many parents would sign?  The consent form necessarily must be a dishonest document.  Here is a legal case for you British barristers.
As I was writing this, the news appeared that the clinical trials of the A-Z vaccine in children were finally paused, just today. Which is 2-3 weeks after the blood clotting issue surfaced.
How well does the Astra-Zeneca vaccine work in the elderly?  Only two months ago the leaders of France and Germany told us:  

Officials in Germany claim the Astra-Zeneca vaccine  is only 8% effective in those over 65. French President Macron has complained to Agence France Press that the A-Z vaccine was only "quasi-ineffective for people over 65."
So, in order to use up the supply, or perhaps for other purposes, Germany will now use the vaccine only in those over 60, and France will use it only in those over 55 -- which are the age groups in which they claimed it didn't work.

In case it is not yet clear, this latest flip-flop from Macron and Merkel (who announced the German restrictions) reveals the truth.  The purpose of the vaccines is obviously not to protect us. 

The vaccines enrich Pharma. The vaccine passports enable much greater control over the citizenry. There may be additional agendas.  

But this is clearly not about our health. 
Forwarded from AnnaN
Forwarded from Deleted Account
I keep seeing contraceptive pill used as a comparison which is a nonsense. The pill is used to prevent pregnancy which in turn has a higher clot risk than being on the pill. The benefit is clear. The benefit of these vaccines for a healthy young women is not.
government.pdf
751.8 KB
SPI-M-O: Summary of further modelling of easing
restrictions – Roadmap Step 2
Date: 31
st March 2021

"32. The resurgence in both hospitalisations and deaths is dominated by those that have
received two doses of the vaccine, comprising around 60% and 70% of the wave
respectively. This can be attributed to the high levels of uptake in the most at-risk age
groups, such that immunisation failures account for more serious illness than unvaccinated
individuals. This is discussed further in paragraphs 55 and 56.

government.pdf
Forwarded from Pat
Possibly the Adenovirus vector...

https://t.co/BMBKcLZEMj : Adenovirus induced thrombocytopenia

https://t.co/4SH35cEpkV : "Although Ad(enovirus) induces thrombocytopenia in both animals and humans, thrombocytopenia itself is not life threatening, as platelets are readily replenished by megakaryocytes. However, the downstream effects of platelet activation and aberrant initiation of coagulation upon Ad injection are dangerous...."

Also : https://t.co/aqZ4VYArvT : seems it's not a good idea to make vaccines from Adenovirus
"Upon vascular injury, locally controlled haemostasis prevents life-threatening blood loss and ensures wound healing. Intracellular material derived from damaged cells at these sites will become exposed to blood components and could contribute to blood coagulation and pathological thrombus formation. So far, the functional and mechanistic consequences of this concept are not understood. Here, we present in vivo and in vitro evidence that different forms of eukaryotic and prokaryotic RNA serve as promoters of blood coagulation. Extracellular RNA was found to augment (auto-)activation of proteases of the contact phase pathway of blood coagulation such as factors XII and XI, both exhibiting strong RNA binding. Moreover, administration of exogenous RNA provoked a significant procoagulant response in rabbits. In mice that underwent an arterial thrombosis model, extracellular RNA was found associated with fibrin-rich thrombi [ BLOOD CLOTS ], and pretreatment with RNase (but not DNase) significantly delayed occlusive thrombus formation. Thus, extracellular RNA derived from damaged or necrotic cells particularly under pathological conditions or severe tissue damage represents the long sought natural “foreign surface” and provides a procoagulant cofactor template for the factors XII/XI-induced contact activation/amplification of blood coagulation. Extracellular RNA thereby reveals a yet unrecognized target for antithrombotic intervention, using RNase or related therapeutic strategies."
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851071/
"Over a decade ago, we completed the Step and Phambili phase 2b studies that evaluated an Ad5 vectored HIV-1 vaccine administered in three immunisations for efficacy against HIV-1 acquisition. Both international studies found an increased risk of HIV-1 acquisition among vaccinated men."

Use of adenovirus type-5 vectored vaccines: a cautionary tale - The Lancet
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32156-5/fulltext
Forwarded from Deleted Account
While adenoviral vectors (Astra Zeneca and Johnson &Johnson) have been tested in far more people than mRNA vaccines, the technology has been used in only one commercial vaccine prior to covid: a rabies vaccine used to immunize wild animals.

https://cen.acs.org/pharmaceuticals/vaccines/Adenoviral-vectors-new-COVID-19/98/i19